Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
about
Selenium for preventing cancerAntioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal ResultsDietary antioxidants and prostate cancer: a reviewFriend or foe? The current epidemiologic evidence on selenium and human cancer riskSelenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.Health risk assessment of environmental selenium: Emerging evidence and challenges (Review)Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial.L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL ratsThe use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatmentSelenium and Human Health: Witnessing a Copernican Revolution?Differential protein expression of Caco-2 cells treated with selenium nanoparticles compared with sodium selenite and selenomethionine.Functional Epigenetic Analysis of Prostate Carcinoma: A Role for Seryl-tRNA Synthetase?A Perspective on Prostate Carcinogenesis and ChemopreventionRandomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neckMethylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.The role of micronutrients in the risk of urinary tract cancer.Selenium supplementation has no effect on serum glucose levels in men at high risk of prostate cancer.Is There a Future for Chemoprevention of Prostate Cancer?A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate.Chronic use of NSAIDs and/or statins does not affect PSA or PSA velocity in men at high risk for prostate cancerSerum selenium levels and the risk of progression of laryngeal cancer.Learning from history in micronutrient research.In vitro antioxidant and anticancer activity of Leea indica leaf extracts on human prostate cancer cell lines.The association between Selenium and Prostate Cancer: a Systematic Review and Meta-AnalysisProstate cancer chemoprevention by natural agents: Clinical evidence and potential implicationsThe Epidemiology of Selenium and Human Health
P2860
Q24197798-77DB65BB-7048-41B3-ADDC-6CE0EEABD05EQ26774897-CD9C25C1-204F-41DE-A5FD-520719032A7DQ26996474-38AA3261-EA06-4894-A9C6-D364EE7C50E0Q27015669-AA97C266-80C4-42A5-A02C-FBEB9A55DAD0Q31112967-14C1CF6B-6E2C-48BC-8C10-717ECC50CB1CQ33671643-D3CA1D5B-F137-4BAE-955C-A6D69A78E41EQ34016998-F848C5BF-FC9C-437E-9EF5-0394D89720FDQ34025688-4A69B0CF-FE5C-4D91-AB1E-ADD76F221784Q34411758-79A01E54-2B85-48A6-B8AA-8B70405F289EQ34480665-5C239639-4A29-4B48-93D3-262132180634Q34559466-A517DE00-4172-4164-851D-42EF6368BC00Q35623572-12C01F83-617B-4B42-8008-F6851D4969CCQ36116269-907147C7-9FAA-4608-95EF-E6435341479AQ36143844-23E1EAE1-6367-408D-9775-398F728F507EQ36446645-49B58CC1-6822-435F-BD93-8128294B0FEEQ36769227-4A2FE290-CEF3-4A77-949B-47C389C46A15Q36845353-7AF35337-9FB5-4F62-B43F-1C7089C9E7C8Q37665076-EA774C15-CA73-4FC0-9625-27471DB6B717Q38878301-2E40D632-CCD7-4E21-823A-88A0862A8AABQ39027111-E45D184B-6C80-4015-8C67-6DE296702D8AQ42433031-45F5CC94-299C-4C49-8334-0F19DB30CE84Q48303390-15B5C0C8-E87A-4521-B8E0-DA210E2CBA0BQ50615510-81CAF98A-9C9E-44CC-AAC5-E04F21ADF502Q54868083-F1E58BCE-D520-4F81-871E-8BF0504B71F6Q57111011-BDEE1CC3-7A04-4F25-99D9-9E252D7D374FQ57112620-5CE5422E-4ACD-4D17-8574-A182E3A3C048Q58800456-4BC5E8CF-E404-45B7-9A3D-F271E58F07D7
P2860
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@ast
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@en
type
label
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@ast
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@en
prefLabel
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@ast
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Phase 3 clinical trial investi ...... high-risk for prostate cancer.
@en
P2093
Amit M Algotar
Bruce L Dalkin
Chiu H Hsu
David L Graham
Elizabeth Slate
Frederick R Ahmann
Howard L Parnes
James Ranger-Moore
John A Tuckey
Lawrence C Clark
P2860
P304
P356
10.1002/PROS.22573
P577
2012-08-10T00:00:00Z